SCHEMBL13347482

SCHEMBL13347482

O=C(O)Cc1ccc(N(CCCO)CCCO)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.48
ALDH1A1 P00352 5/20 0.47
LMNA P02545 4/20 0.47
HIF1A Q16665 4/20 0.47
TSHR P16473 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
MAPT P10636 3/20 0.47
NFKB1 P19838 3/20 0.47
THPO P40225 3/20 0.47
PMP22 Q01453 3/20 0.47
GMNN O75496 1/20 0.47
CYP2D6 P10635 1/20 0.47
GABRA1 P14867 1/20 0.47
GABRA2 P47869 1/20 0.47
GABRB2 P47870 1/20 0.47
SLCO1B3 Q9NPD5 1/20 0.47
CA2 P00918 1/20 0.47
CAMK2A Q9UQM7 1/20 0.47
AKR1B1 P15121 1/20 0.45
HPGD P15428 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12102412 0.89 NR3C1 (0.50) NR3C1ALDH1A1LMNAHIF1ATSHR
SCHEMBL5449533 0.84 ALDH1A1 (0.61) NR3C1ALDH1A1LMNAHIF1ATSHR
SCHEMBL14496299 0.81 ALDH1A1 (0.60) NR3C1ALDH1A1HPGDHSD17B10CNR2
SCHEMBL2782797 0.80 ALDH1A1 (0.36) ALDH1A1LMNAHIF1ATSHRSMN1; SMN2
Chlorphenacyl SCHEMBL7468547 0.80 LMNA (0.66) NR3C1ALDH1A1LMNAHIF1ATSHR
SCHEMBL10521360 0.80 NR3C1 (0.49) NR3C1ALDH1A1LMNAHIF1ATSHR
SCHEMBL1230226 0.78 RARB (0.47) ALDH1A1LMNAHIF1ATSHRSMN1; SMN2
SCHEMBL5444108 0.77 AKR1B1 (0.59) NR3C1ALDH1A1LMNAHIF1ATSHR
SCHEMBL6031089 0.77 ALDH1A1 (0.51) NR3C1ALDH1A1LMNAHIF1ATSHR
SCHEMBL3729424 0.76 AOC3 (0.58) NR3C1ALDH1A1LMNATSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7713634-B2 Non-linear silicon compound, method of manufacturing oligomer probe array using the same, substrate for oligomer probe array with the same, and oligomer probe array with the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2010-05-11 US disclosed
US-7713634-B2 Non-linear silicon compound, method of manufacturing oligomer probe array using the same, substrate for oligomer probe array with the same, and oligomer probe array with the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2010-05-11 US disclosed
US-20080057322-A1 Non-Linear Silicon Compound, Method of Manufacturing Oligomer Probe Array Using the Same, Substrate For Oligomer Probe Array With the Same, and Oligomer Probe Array With the Same SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-03-06 US disclosed
US-20080057322-A1 Non-Linear Silicon Compound, Method of Manufacturing Oligomer Probe Array Using the Same, Substrate For Oligomer Probe Array With the Same, and Oligomer Probe Array With the Same SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080057322-A1 Non-Linear Silicon Compound, Method of Manufacturing Oligomer Probe Array Using the Same, Substrate For Oligomer Probe Array With the Same, and Oligomer Probe Array With the Same NONO, SPTBN1, SKIC8 NR3C1 4301/4885ALDH1A1 4399/4885LMNA 2142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.